Pancreatic cancer is one of the solid tumors with the worst prognosis. The overall survival rate after surgical resection of pancreatic cancer is quite low. Gemcitabine monotherapy and its combination therapy are the preferred treatment for pancreatic cancer. But it is easy for gemcitabine to generate drug resistance in vivo, which seriously affects the prognosis. In order to solve the drug resistance problem of gemcitabine, researchers have conducted many explorations and studies on new delivery systems such as liposomes, nanoparticles, and micelles. In this paper, the mechanism of gemcitabine resistance is introduced, and the application of gemcitabine nano-delivery systems in treating pancreatic cancer is reviewed to provide a reference for the gemcitabine delivery system development.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |